Skip to content
Twitter page opens in new window
Linkedin page opens in new window
Instagram page opens in new window
investorenquiries@pharmaust.com
+61 8 9202 6814
PharmAust (PAA)
Cancer Therapeutics Research
HOME
ABOUT
Board
Corporate Directory
PIPELINES & TRIALS
Monepantel for Motor Neurone Disease
Monepantel for Canine Cancer
Veterinary Study Details
Monepantel for Human Cancer
Publications
INVESTOR CENTRE
ASX Announcements
Annual Reports
Investor Presentations
PhamAust AGM 2022
Company Research
Financial Reports
Corporate Governance
Top 20 Shareholders
MEDIA
Podcast Episode 18: Dr Kim Agnew, PharmAust
Fireside Chat with Dr Roger Aston
Fireside Chat with Dr Kim
PharmAust Webinar
Epichem Webinar
BB PAA Video – September 2021
OHD Benchtop Flow Reactor Launch
Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
Interview with TechInvest – May 2020
Dr. Richard Mollard – 6IX Interview March 2020
PharmAust In the News
PharmAust Videos
PharmAust New Cancer Treatment
PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
PharmAust on Youtube
CONTACT
HOME
ABOUT
Board
Corporate Directory
PIPELINES & TRIALS
Monepantel for Motor Neurone Disease
Monepantel for Canine Cancer
Veterinary Study Details
Monepantel for Human Cancer
Publications
INVESTOR CENTRE
ASX Announcements
Annual Reports
Investor Presentations
PhamAust AGM 2022
Company Research
Financial Reports
Corporate Governance
Top 20 Shareholders
MEDIA
Podcast Episode 18: Dr Kim Agnew, PharmAust
Fireside Chat with Dr Roger Aston
Fireside Chat with Dr Kim
PharmAust Webinar
Epichem Webinar
BB PAA Video – September 2021
OHD Benchtop Flow Reactor Launch
Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
Interview with TechInvest – May 2020
Dr. Richard Mollard – 6IX Interview March 2020
PharmAust In the News
PharmAust Videos
PharmAust New Cancer Treatment
PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
PharmAust on Youtube
CONTACT
Top 20 Shareholders November 2022
Top_Holders_Report NOV
Go to Top